Search for: "ASTRAZENECA LP"
Results 101 - 120
of 138
Sort by Relevance
|
Sort by Date
29 Apr 2010, 7:43 am
Department Of Justice announced that it has entered into an agreement with AstraZeneca LP and AstraZeneca Pharmaceuticals LP to settle a False Claims Act lawsuit alleging that the companies submitted claims for payment to U.S. government health agencies (such as Medicare, Medicaid, and TRICARE) in connection with a scheme to illegally market the anti-psychotic drug Seroquel for uses that were not approved as safe and effective by the Food and Drug Administration. [read post]
28 Apr 2010, 7:14 am
From the DOJ Press Statement:AstraZeneca LP and AstraZeneca Pharmaceuticals LP will pay $520 million to resolve allegations that AstraZeneca illegally marketed the anti-psychotic drug Seroquel for uses not approved as safe and effective by the Food and Drug Administration (FDA), the Departments of Justice and Health and Human Services’ Health Care Fraud Enforcement Action Team (HEAT) announced today. [read post]
28 Apr 2010, 7:00 am
Cuomo today announced that New York state will receive nearly $45 million as part of a $520 million federal and multi-state settlement with AstraZeneca LP (NYSE: AZN) concerning allegations that the large pharmaceutical company provided kickbacks to doctors and engaged in an off-label marketing campaign to promote its antipsychotic drug Seroquel. [read post]
16 Apr 2010, 3:30 am
AstraZeneca Pharmaceuticals, LP, 2010 WL 1267219 (Del. [read post]
19 Mar 2010, 10:31 am
AstraZeneca Pharmaceuticals LP, MID L 1099 07 MT, Superior Court of New Jersey, Law Division, Middlesex County (New Brunswick). [read post]
17 Feb 2010, 8:00 am
Aquatron Inc. and Aqua Group LLC (patent infringement) 1/7: AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited and AstraZeneca AB v. [read post]
10 Feb 2010, 4:47 pm
(Patent Docs) Colmetec (Olmesartan medoxomil, hydrochlorothiazide) – France: Cour d’appel de Paris say ‘non’ to olmesartan medoxomil and hydrochlorothiazide combination SPC: Daiichi Sankyo Company v INPI (SPC Blog) Crestor (Rosuvastatin) – US: Generic drug makers, Teva, Apotex and others seek to remove AstraZeneca LP as party in Crestor suit (Patent Docs) Differin (Adapalene) – US: Patent infringement complaint following a Paragraph IV… [read post]
25 Jan 2010, 5:00 am
As we said last week, because it’s a Dechert case, we can’t comment directly on Clark v. [read post]
21 Jan 2010, 1:00 am
(Patent Docs) Faslodex (Fulvestrant) - US: Infringement of US Patent following a Paragraph IV certification: AstraZeneca Pharmaceuticals LP et al. v. [read post]
12 Jan 2010, 7:26 am
"); AstraZeneca LP v. [read post]
24 Dec 2009, 11:32 am
AstraZeneca LP v. [read post]
4 Dec 2009, 5:00 am
See AstraZeneca LP v. [read post]
8 Oct 2009, 6:05 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Seroquel (Quetiapine) – US: CAFC: Sometimes, sins of omission are not inequitable conduct: AstraZeneca Pharmaceuticals LP v. [read post]
7 Oct 2009, 5:30 pm
AstraZeneca LP v. [read post]
28 Sep 2009, 9:56 pm
Sometimes, Sins of Omission Are Not Inequitable Conduct By Kevin E. [read post]
23 Sep 2009, 10:02 pm
AstraZeneca Pharmaceuticals LP, No. 08-1056 (1st Cir. [read post]
28 Aug 2009, 8:11 am
Hewlett-Packard Company, AstraZeneca Pharmaceuticals LP, Dow Chemical Company, Advanced Micro Devices, Inc., Dreamworks Animation SKG, et al. [read post]
16 Aug 2009, 9:58 pm
Astrazeneca LP et al. v. [read post]
23 Jul 2009, 3:15 am
Astrazeneca Pharmaceuticals LP), because of Bexis' firm's involvement in the litigation (although not this aspect). [read post]
27 May 2009, 12:44 am
"AstraZeneca LP v. [read post]
